The University of Alberta Hospital is a research and teaching hospital in Edmonton, Alberta, Canada. The hospital is affiliated with the University of Alberta and run by Alberta Health Services, the health authority for Alberta.

There are 885 beds in University of Alberta Hospital.

During the past decade, University of Alberta Hospital conducted 248 clinical trials. In the 10-year time frame, 248 clinical trials started and 109 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 116 clinical trials started and 54 clinical trials were completed. i.e. 46.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alberta Hospital" #1 sponsor was "University of Alberta" with 124 trials, followed by "Children's Oncology Group" with 69 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 10 trials sponsored and "Boehringer Ingelheim" with 10 trials sponsored. Other sponsors include 253 different institutions and companies that sponsored additional 141 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alberta Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 34 trials as a collaborator, "University of Alberta" with 12 trials as a collaborator, "Alberta Health services" with 11 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator. Other collaborators include 320 different institutions and companies that were collaborators in the rest 220 trials.

According to Clinical.Site data, the most researched conditions in "University of Alberta Hospital" are "Atrial Fibrillation" (13 trials), "Myocardial Infarction" (11 trials), "Heart Failure" (10 trials), "Pulmonary Arterial Hypertension" (10 trials) and "Stroke" (10 trials). Many other conditions were trialed in "University of Alberta Hospital" in a lesser frequency.

Most popular intervention types in "University of Alberta Hospital" are "Drug" (280 trials), "Other" (112 trials), "Biological" (74 trials), "Procedure" (72 trials) and "Device" (50 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (69 trials), "Laboratory Biomarker Analysis" (33 trials), "Cyclophosphamide" (29 trials), "Vincristine Sulfate" (23 trials) and "Doxorubicin Hydrochloride" (19 trials). Other intervention names were less common.

The vast majority of trials in "University of Alberta Hospital" are 475 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 158 active trials in "University of Alberta Hospital". 3 are not yet recruiting, 94 are recruiting, 59 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 247 completed trials in University of Alberta Hospital, 3 suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alberta Hospital, 28 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 186 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 37 trials, and there were also 100 trials that are defined as “Not Applicable".

University of Alberta Hospital has several departments that took part in Clinical trials: "Glenrose Rehabilitation Hospital" - 25 trials, "Forzani & MacPhail Colon Cancer Screening Centre" - 8 trials, "Cross Cancer Institute" - 753 trials, "Tom Baker Cancer Centre - Holy Cross Site" - 3 trials, "Mazankowski Alberta Heart Institute" - 30 trials, "Psychosocial Oncology, Cancer Control Alberta" - 3 trials, "University of Alberta Hospital, outpatient dialysis unit" - 2 trials